课题基金 / 基金详情

CTL responses to vaccination in CRPV rabbit model

CTL responses to vaccination in CRPV rabbit model
CRPV 兔模型中 CTL 对疫苗接种的反应
批准号:
6318510
负责人:
JANET L BRANDSMA
金额:
$7.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 2004-03-31

项目摘要

项目成果

JANET L BRANDSMA的其他基金

相似基金

相关文献

中文摘要
翻译
子宫颈癌是由感染高危人乳头瘤病毒(hpv)引起的。这种癌症的病毒病原学表明,应该有可能开发出高度特异性和有效的抗病毒和抗肿瘤疫苗。HPV感染和相关病变的控制被认为是通过细胞毒性T细胞(ctl)的作用介导的。研究高危(癌症相关)乳头瘤病毒感染的唯一小动物模型是棉尾兔乳头瘤病毒(CRPV)-兔模型。使用这个模型,我的实验室已经生产了许多CRPV疫苗,这些疫苗可以保护兔子免受原发性CRPV感染,或者抑制预先感染的临床表现。我们超越目前体内结果的能力受到兔子CTL测定目前不可用这一事实的阻碍。由于免疫学的最新进展使开发兔CTL测定成为可能,这是我们项目的目标。我们的具体目标是:1)为CTL靶点的发展提供一种永生细胞的来源;2)生成抗原特异性靶细胞;3)利用免疫兔的效应细胞建立CTL测定。
英文摘要
Cervical cancer is caused by infection with high-risk human papillomaviruses (HPVs). The viral etiology of this cancer indicates that it should be possible to develop highly specific and effective antiviral and antitumor vaccines. The control of HPV infection and associated lesions is believer to be mediated through the action of cytotoxic T cells (CTLs). The only small animal model for the study of high risk (cancer-associated) papillomavirus infection is the cottontail rabbit papillomavirus (CRPV)-rabbit model. Using this model, my laboratory has produced a number of CRPV vaccines that protect rabbits against primary CRPV infection or that suppress the clinical manifestations of a preestablished infection. Our ability to advance beyond the current in vivo results is hindered by the fact that a CTL assay for rabbits is currently not available. Since recent advances in immunology make it feasible to develop a rabbit CTL assay, this is the goal of our project. Our specific aims are: 1) to produce a source of immortal cells for the development of CTL targets; 2) to generate antigen-specific target cells; 3) to develop a CTL assay using effector cells from vaccinated rabbits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Langerhans cell-mediated immune modulation of HPV8 expression and tumorgenesis
  • 批准号:
    7530393
  • 项目类别:
  • 资助金额:
    $18.62万
  • 财政年份:
    2008
  • 负责人:
    JANET L BRANDSMA
  • 依托单位:
Langerhans cell-mediated immune modulation of HPV8 expression and tumorgenesis
  • 批准号:
    7624197
  • 项目类别:
  • 资助金额:
    $22.34万
  • 财政年份:
    2008
  • 负责人:
    JANET L BRANDSMA
  • 依托单位:
Papillomavirus E2 as a cervical/anal cancer drug target
  • 批准号:
    6915013
  • 项目类别:
  • 资助金额:
    $24.53万
  • 财政年份:
    2004
  • 负责人:
    JANET L BRANDSMA
  • 依托单位:
Papillomavirus E2 as a cervical/anal cancer drug target
  • 批准号:
    6844396
  • 项目类别:
  • 资助金额:
    $23.39万
  • 财政年份:
    2004
  • 负责人:
    JANET L BRANDSMA
  • 依托单位:
海外基金